Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells.

Oncotarget · 2017 · PMC5663539 · PMID 29137367

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Consistent with the results we obtained using unlabeled experiments, the SIRM results showed a trend of lower glucose consumption and lactate production in the PCK2-knockdown cells compared to the controls (Figures 4E ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.